Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced that there have been no significant developments in the bankruptcy liquidation proceedings of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since the last update. The company remains committed to monitoring the situation closely, maintaining communication with relevant parties, and safeguarding shareholder interests, while continuing to provide monthly updates as per regulatory requirements.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, operates in the pharmaceutical industry. The company, along with its subsidiaries, focuses on the development and production of pharmaceutical products in the People’s Republic of China.
For a thorough assessment of 2TZ stock, go to TipRanks’ Stock Analysis page.